Detection of EGFR mutations by TaqMan mutation detection assays powered by competitive allele-specific taqman PCR technology

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Roma, Cristin ^a   Esposito, Claudia ^a   Rachiglio, Anna Maria ^a   Pasquale, Raffaella ^a   Iannaccone, Alessia ^a   Chicchinelli, Nicoletta ^a   Franco, Renato ^a   Mancini, Rita ^b   Pisconti, Salvatore ^c   De Luca, Antonella ^a   Botti, Gerardo ^a   Morabito, Alessandro ^a   Normanno, Nicola ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SS Annunziata Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR;

ALLELE; ARTICLE; COLORECTAL TUMOR; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LUNG NON SMALL CELL CANCER; MUTATION; PATHOLOGY; POLYMERASE CHAIN REACTION;

ALLELES; CARCINOMA, NON-SMALL-CELL LUNG; COLORECTAL NEOPLASMS; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84893813926     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/385087     Document Type: Article

References (18)

1. Garraway L. A., Genomics-driven oncology: framework for an emerging paradigm. Journal Clinical Oncology 2013 31 15 1806 1814 10.1200/JCO.2012.46. 8934
2. Dienstmann R., Rodon J., Barretina J., Tabernero J., Genomic medicine frontier in human solid tumors: prospects and challenges. Journal Clinical Oncology 2013 31 15 1874 1884 10.1200/JCO.2012.45.2268
3. Normanno N., Rachiglio A. M., Roma C., Fenizia F., Esposito C., Pasquale R., La Porta M. L., Iannaccone A., Micheli F., Santangelo M., Bergantino F., Costantini S., De Luca A., Molecular diagnostics and personalized medicine in oncology: challenges and opportunities. Journal of Cellular Biochemistry 2013 114 3 514 524 10.1002/jcb.24401
4. Rossi A., Pasquale R., Esposito C., Normanno N., Should epidermal growth factor receptor tyrosine kinase inhibitors be considered ideal drugs for the treatment of selected advanced non-small cell lung cancer patients? Cancer Treatment Reviews 2013 39 5 489 497 10.1016/j.ctrv.2012.09.001
5. De Luca A., Normanno N., Predictive biomarkers to tyrosine kinase inhibitors for the epidermal growth factor receptor in non-small-cell lung cancer. Current Drug Targets 2010 11 7 851 864 2-s2.0-77954718424 10.2174/138945010791320773
6. Sharma S. V., Bell D. W., Settleman J., Haber D. A., Epidermal growth factor receptor mutations in lung cancer. Nature Reviews Cancer 2007 7 3 169 181 2-s2.0-33847323129 10.1038/nrc2088
7. Marchetti A., Normanno N., Pinto C., Taddei G. L., Adamo V., Ardizzoni A., Botti G., Bardelli A., Comin C., Crinò L., Fontanini G., Gambacorta M., Marchetti A., Murer B., Normanno N., Nappi O., Recommendations for mutational analysis of ECFR in lung carcinoma. Pathologica 2010 102 3 119 126 2-s2.0-77956931328
8. Warth A., Penzel R., Brandt R., Sers C., Fischer J. R., Thomas M., Herth F. J., Dietel M., Schirmacher P., Bläker H., Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies. Virchows Archiv 2012 460 4 407 414 2-s2.0-84857956914 10.1007/s00428-012-1219-x
9. Ellison G., Zhu G., Moulis A., Dearden S., Speake G., McCormack R., EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. Journal of Clinical Pathology 2013 66 2 79 89 10.1136/jclinpath-2012-201194
10. Didelot A., Le Corre D., Luscan A., Cazes A., Pallier K., Emile J.-F., Laurent-Puig P., Blons H., Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples. Experimental and Molecular Pathology 2012 92 3 275 280 2-s2.0-84858961916 10.1016/j.yexmp.2012.03.001
11. Carotenuto P., Roma C., Rachiglio A. M., Tatangelo F., Pinto C., Ciardiello F., Nappi O., Iaffaioli R. V., Botti G., Normanno N., Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach. Pharmacogenomics 2010 11 8 1169 1179 2-s2.0-77955597394 10.2217/pgs.10.86
12. Rosell R., Moran T., Queralt C., Porta R., Cardenal F., Camps C., Majem M., Lopez-Vivanco G., Isla D., Provencio M., Insa A., Massuti B., Gonzalez-Larriba J. L., Paz-Ares L., Bover I., Garcia-Campelo R., Moreno M. A., Catot S., Rolfo C., Reguart N., Palmero R., Sánchez J. M., Bastus R., Mayo C., Bertran-Alamillo J., Molina M. A., Sanchez J. J., Taron M., Screening for epidermal growth factor receptor mutations in lung cancer. The New England Journal of Medicine 2009 361 10 958 967 2-s2.0-69949186250 10.1056/NEJMoa0904554
13. Goto K., Satouchi M., Ishii G., Nishio K., Hagiwara K., Mitsudomi T., Whiteley J., Donald E., McCormack R., Todo: T., An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Annals of Oncology 2012 23 11 2914 2919 10.1093/annonc/mds121
14. Coghlin C. L., Smith L. J., Bakar S., Stewart K. N., Devereux G. S., Nicolson M. C., Kerr K. M., Quantitative analysis of tumor in bronchial biopsy specimens. Journal of Thoracic Oncology 2010 5 4 448 452 2-s2.0-77951021505 10.1097/JTO.0b013e3181ca12c4
15. Bai H., Wang Z., Chen K., Zhao J., Lee J. J., Wang S., Zhou Q., Zhuo M., Mao L., An T., Duan J., Yang L., Wu M., Liang Z., Wang Y., Kang X., Wang J., Influence of chemotherapy on EGFR mutation status among patients with non-small-cell lung cancer. Journal of Clinical Oncology 2012 30 25 3077 3083 10.1200/JCO.2011.39.3744
16. Normanno N., Pinto C., Taddei G., Gambacorta M., Castiglione F., Barberis M., Clemente C., Marchetti A., Results of the first Italian External Quality Assurance Scheme for somatic EGFR mutation testing in non-small-cell lung cancer. Journal of Thoracic Oncology 2013 8 6 773 778 10.1097/JTO. 0b013e31828c2b08
17. Penzel R., Sers C., Chen Y., Lehmann-Mühlenhoff U., Merkelbach-Bruse S., Jung A., Kirchner T., Büttner R., Kreipe H. H., Petersen I., Dietel M., Schirmacher P., EGFR mutation detection in NSCLC-assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Archiv 2011 458 1 95 98 2-s2.0-78651339071 10.1007/s00428-010- 1000-y
18. Zhou Q., Zhang X.-C., Chen Z.-H., Yin X.-L., Yang J.-J., Xu C.-R., Yan H.-H., Chen H.-J., Su J., Zhong W.-Z., Yang X.-N., An S.-J., Wang B.-C., Huang Y.-S., Wang Z., Wu Y.-L., Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer. Journal of Clinical Oncology 2011 29 24 3316 3321 2-s2.0-80051965827 10.1200/JCO.2010.33. 3757